Cite
Beneficial effects of intermediate dosage of anticoagulation treatment on the prognosis of hospitalized COVID-19 patients: The ETHRA study
MLA
Poulakou, G.Dimakakos, E.Kollias, A.Kyriakoulis, K. G.Rapti, V.Trontzas, I.Thanos, C.Abdelrasoul, M.Vantana, T.Leontis, K.Kakalou, E.Argyraki, K.Baraboutis, I.Michelakis, E.Giamarellos-Bourboulis, E.Dimakou, K.Tsoukalas, G.Rapti, A.Michelakis, E. D.Syrigos, K. N. Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study. Jan. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..60904b904e1a2af798ac6224752678f2&authtype=sso&custid=ns315887.
APA
Poulakou, G. D. E. K. A. K. K. G. R. V. T. I. T. C. A. M. V. T. L. K. K. E. A. K. B. I. M. E. G.-B. E. D. K. T. G. R. A. M. E. D. S. K. N. (2021). Beneficial effects of intermediate dosage of anticoagulation treatment on the prognosis of hospitalized COVID-19 patients: The ETHRA study.
Chicago
Poulakou, G. Dimakakos, E. Kollias, A. Kyriakoulis, K.G. Rapti, V. Trontzas, I. Thanos, C. Abdelrasoul, M. Vantana, T. Leontis, K. Kakalou, E. Argyraki, K. Baraboutis, I. Michelakis, E. Giamarellos-Bourboulis, E. Dimakou, K. Tsoukalas, G. Rapti, A. Michelakis, E.D. Syrigos, K.N. 2021. “Beneficial Effects of Intermediate Dosage of Anticoagulation Treatment on the Prognosis of Hospitalized COVID-19 Patients: The ETHRA Study,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.od......2127..60904b904e1a2af798ac6224752678f2&authtype=sso&custid=ns315887.